Eur Rev Med Pharmacol Sci 2020; 24 (13): 7221-7221

DOI: 10.26355/eurrev_202007_21872

GBP1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Wnt/β-catenin signaling pathway

J. Song, Q.-Y. Wei

Department of Geriatrics, DaLian Friendship Hospital, Dalian, China.


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “GBP1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Wnt/β-catenin signaling pathway, by J. Song, Q.-Y. Wei, published in Eur Rev Med Pharmacol Sci 2020; 24 (10): 5465-5472–DOI: 10.26355/eurrev_202005_21331–PMID: 32495881” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

GBP1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Wnt/β-catenin signaling pathway

Free PDF Download

To cite this article

J. Song, Q.-Y. Wei
GBP1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Wnt/β-catenin signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 13
Pages: 7221-7221
DOI: 10.26355/eurrev_202007_21872